JAZZ 8-K 2026-08-10

Jazz Pharmaceuticals plc (JAZZ) 8-K dated 2026-08-10 — accession 0001193125-26-341270. This URL is the filing, not the JAZZ hub.

Jazz Pharmaceuticals plc (JAZZ) is a biotechnology company listed on US.

Jazz Pharmaceuticals plc filed a 8-K on 2026-08-10. Accession 0001193125-26-341270.

Cached items: 7.01, 9.01. EDGAR remains the official archive; Lician keeps this accession as its own indexable page so Google can recrawl the form, not a ticker dump.

Latest reported JAZZ revenue for 2026-06-30 was $2.28B. Net income was $485.9M. JAZZ currently screens at market cap $14.97B and trailing P/E 1988.1.

Not investment advice. The JAZZ SEC hub lists recent forms. The stock page is the research view.